Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neurostimulation for Parkinson's disease with early motor complications.
Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Hälbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltête D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Krüger R, Pinsker MO, Amtage F, Régis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G; EARLYSTIM Study Group. Schuepbach WM, et al. N Engl J Med. 2013 Feb 14;368(7):610-22. doi: 10.1056/NEJMoa1205158. N Engl J Med. 2013. PMID: 23406026 Free article. Clinical Trial.
Transdermal Nicotine Treatment and Progression of Early Parkinson's Disease.
Oertel WH, Müller HH, Unger MM, Schade-Brittinger C, Balthasar K, Articus K, Brinkman M, Venuto CS, Tracik F, Eberling J, Eggert KM, Kamp C, Kieburtz K, Boyd JT. Oertel WH, et al. Among authors: schade brittinger c. NEJM Evid. 2023 Sep;2(9):EVIDoa2200311. doi: 10.1056/EVIDoa2200311. Epub 2023 Aug 22. NEJM Evid. 2023. PMID: 38320207 Clinical Trial.
Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trial.
van Beek N, Eming R, Reuss A, Zillikens D, Sárdy M, Günther C, Kiritsi D, Benoit S, Beissert S, Gläser R, Gollnick H, Horváth ON, Pfeiffer C, Röcken M, Schauer F, Schreml S, Steinbrink K, Zink A, Schade-Brittinger C, Hertl M, Schmidt E. van Beek N, et al. Among authors: schade brittinger c. Br J Dermatol. 2024 Apr 17;190(5):657-667. doi: 10.1093/bjd/ljad489. Br J Dermatol. 2024. PMID: 38133541 Clinical Trial.
Culturally adapted cognitive behavioural group therapy for mental disorders in refugees plus problem solving training (ReTreat): study protocol for a multicentre randomised controlled trial.
Kananian S, Kip A, Schumm H, Giesebrecht J, Nicolai A, Schade-Brittinger C, Reese JP, Weise C, Mewes R, Morina N, Ehring T, Stangier U. Kananian S, et al. Among authors: schade brittinger c. BMJ Open. 2022 Nov 11;12(11):e061274. doi: 10.1136/bmjopen-2022-061274. BMJ Open. 2022. PMID: 36368748 Free PMC article.
Pre-surgery optimization of patients' expectations to improve outcome in heart surgery: Study protocol of the randomized controlled multi-center PSY-HEART-II trial.
Salzmann S, Laferton JAC, Shedden-Mora MC, Horn N, Gärtner L, Schröder L, Rau J, Schade-Brittinger C, Murmann K, Rastan A, Andrási TB, Böning A, Salzmann-Djufri M, Löwe B, Brickwedel J, Albus C, Wahlers T, Hamm A, Hilker L, Albert W, Falk V, Zimmermann T, Ismail I, Strauß B, Doenst T, Schedlowski M, Moosdorf R, Rief W. Salzmann S, et al. Among authors: schade brittinger c. Am Heart J. 2022 Dec;254:1-11. doi: 10.1016/j.ahj.2022.07.008. Epub 2022 Aug 5. Am Heart J. 2022. PMID: 35940247 Free article.
The Efficacy of Short-Term Bridging Strategies With High- and Low-Dose Prednisolone on Radiographic and Clinical Outcomes in Active Early Rheumatoid Arthritis: A Double-Blind, Randomized, Placebo-Controlled Trial.
Krause D, Mai A, Klaassen-Mielke R, Timmesfeld N, Trampisch U, Rudolf H, Baraliakos X, Schmitz E, Fendler C, Klink C, Boeddeker S, Saracbasi-Zender E, Christoph HJ, Igelmann M, Menne HJ, Schmid A, Rau R, Wassenberg S, Sonuc N, Ose C, Schade-Brittinger C, Trampisch HJ, Braun J. Krause D, et al. Among authors: schade brittinger c. Arthritis Rheumatol. 2022 Oct;74(10):1628-1637. doi: 10.1002/art.42245. Arthritis Rheumatol. 2022. PMID: 35643951 Clinical Trial.
Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial.
McLaughlin PMJ, Klar M, Zwimpfer TA, Dutilh G, Vetter M, Marth C, du Bois A, Schade-Brittinger C, Reuss A, Bommer C, Kurzeder C, Heinzelmann-Schwarz V. McLaughlin PMJ, et al. Among authors: schade brittinger c. BMC Cancer. 2022 May 6;22(1):508. doi: 10.1186/s12885-022-09555-8. BMC Cancer. 2022. PMID: 35524184 Free PMC article.
Safety of Triage Self-assessment Using a Symptom Assessment App for Walk-in Patients in the Emergency Care Setting: Observational Prospective Cross-sectional Study.
Cotte F, Mueller T, Gilbert S, Blümke B, Multmeier J, Hirsch MC, Wicks P, Wolanski J, Tutschkow D, Schade Brittinger C, Timmermann L, Jerrentrup A. Cotte F, et al. Among authors: schade brittinger c. JMIR Mhealth Uhealth. 2022 Mar 28;10(3):e32340. doi: 10.2196/32340. JMIR Mhealth Uhealth. 2022. PMID: 35343909 Free PMC article.
Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in female outpatients with anorexia nervosa (ANTOP study): 5-year follow-up of a randomised controlled trial in Germany.
Herzog W, Wild B, Giel KE, Junne F, Friederich HC, Resmark G, Teufel M, Schellberg D, de Zwaan M, Dinkel A, Herpertz S, Burgmer M, Löwe B, Zeeck A, von Wietersheim J, Tagay S, Schade-Brittinger C, Schauenburg H, Schmidt U, Zipfel S. Herzog W, et al. Among authors: schade brittinger c. Lancet Psychiatry. 2022 Apr;9(4):280-290. doi: 10.1016/S2215-0366(22)00028-1. Epub 2022 Mar 13. Lancet Psychiatry. 2022. PMID: 35294860 Clinical Trial.
84 results